Hostname: page-component-84b7d79bbc-5lx2p Total loading time: 0 Render date: 2024-07-25T08:01:59.839Z Has data issue: false hasContentIssue false
  • English
  • Français

Discussant Remarks

Published online by Cambridge University Press:  03 March 2022

Hannah L. Buxbaum
Hannah L. Buxbaum*
Affiliation:
Professor of Law and John E. Schiller Chair, Indiana University Maurer School of Law; Vice President for International Affairs, Indiana University.
Get access Rights & Permissions [Opens in a new window]

Extract

Through the lens of current crises—including the climate crisis, the crisis of democracy, and of course the COVID-19 pandemic—Professor Daudet examines the role that international law plays in mediating the principle of national sovereignty and the interests of the global community. He goes on to inquire whether these crises might in some way create an opportunity to advance the international legal and political order.

Type
Twenty-Third Annual Grotius Lecture on International Law
Information
Proceedings of the ASIL Annual Meeting , Volume 115 , 2021 , pp. 141 - 144
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of The American Society of International Law.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

82 Yves Daudet, “Never Let a Good Crisis Go to Waste”: Can International Law Seize The Advantage?, 115 Am. Soc'y Int'l L. Proc. 129 (2021); see also 37 Am. U. Int'l L. Rev. (2022).

83 See generally Hilary Charlesworth, International Law: A Discipline of Crisis, 65 Modern L. Rev. 377 (2002).

84 Daudet, supra note 82 at 132.

85 Id.

86 See, e.g., Louis Charbonneau, Multilateralism Under Threat, Hum. Rts. Watch (June 24, 2019, 11:14 AM), https://www.hrw.org/news/2019/06/24/multilateralism-under-threat# (discussing the Trump administration's work to decrease funding to the UN and other international organizations).

87 See Wolfgang Friedmann, National Sovereignty, International Cooperation, and the Reality of International Law, 10 UCLA L. Rev. 739, 739, 747–48 (1963) (describing the emergence of cooperative international law); Wolfgang Friedmann, The Changing Structure of International Law 89 (1964) (contrasting traditional systems of international law regulating the rules of coexistence between States and new rules focused on principles of cooperation advancing common interests).

88 Yves Daudet, 1919-2019, Le Flux du Multilatéralisme, 403 Recueil des Cours 9 (2019).

89 See Daudet, supra note 82 at 129.

90 Id. at 141.

91 See, e.g., the statement by UN Secretary-General António Guterres, June 10, 2020 (indicating the need for “a strong, coordinated and coherent multilateral response based on solidarity”), https://www.un.org/press/en/2020/sgsm20115.doc.htm.

92 Daudet, supra note 82 at 139.

93 See generally Claire Felter, A Guide to Global COVID-19 Vaccine Efforts, Council on Foreign Rels. (Oct. 11, 2021, 1:45 PM), https://www.cfr.org/backgrounder/guide-global-covid-19-vaccine-efforts (stating that more than twenty COVID-19 vaccines were globally approved for use).

94 See United Nations Declaration on the Establishment of a New International Economic Order, A/Res/S-6/3201 (May 1, 1974).

95 See, e.g., Georges Abi-Saab, Whither the International Community?, 9 Eur. J. Int'l L. 248, 265 (1998) (describing international development law as “stopped dead in its evolution”).

96 Agreement on Trade-Related Aspects of International Property Rights, arts. 27.1, 33, Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S 299 (1994) (granting patent protection for at least twenty years on new inventions, whether products or processes).

97 See OECD, Coronavirus (COVID-19) Vaccines for Developing Countries: An Equal Shot at Recovery 3 (2021), https://www.oecd-ilibrary.org/social-issues-migration-health/coronavirus-covid-19-vaccines-for-developing-countries-an-equal-shot-at-recovery_6b0771e6-en.

98 See TRIPS Council Agrees to Continue Discussions on IP Response to COVID-19, WTO (July 20, 2021), https://www.wto.org/english/news_e/news21_e/trip_20jul21_e.htm (chronicling the TRIPS waiver discussions at the WTO).

99 See generally Gavi, Covax, https://www.gavi.org/covax-facility. \

100 See Seth Berkley, COVAX Explained, Gavi (Sept. 3, 2020), https://www.gavi.org/vaccineswork/covax-explained (describing the initial target of raising $2 billion, primarily through development assistance from sovereign donors, to support vaccine research and production, and stating that COVAX is the “only viable way” for lower-income countries to obtain COVID-19 vaccines).

101 See Laurence Norman & Jenny Strasburg, Vaccine Fight Between EU and U.K., WSJ (Mar. 22, 2021), https://www.wsj.com/articles/vaccine-fight-between-eu-and-u-k-threatens-to-escalate-11616444756 (discussing the European Union's potential ban on exports of the AstraZeneca vaccine from the Netherlands to the United Kingdom).

102 See Sarah A. Lister et al., Cong. Rsch. Serv., R46861, Health Equity and Disparities During the COVID-19 Pandemic: Brief Overview of the Federal Role 4–6 (2021) (stating that Black, Indigenous, People of Color, elderly, and rural populations are disproportionately at risk for COVID-19).

103 See Daudet, supra note 82 at 137.